You are invited to the following presentation:
The only once-daily, oral maintenance therapy for all eligible first-line platinum responders with advanced ovarian cancer, regardless of biomarker status
Details:
• Learn about the role of maintenance therapy in advanced ovarian cancer
• Review the efficacy and safety profile of ZEJULA as 1L maintenance therapy in advanced ovarian cancer
• Understand considerations for prescribing ZEJULA in clinical practice
Presented By:
Kimberly Nichols, RN, BSN, OCN
GSK
Date/Time:
Monday, January 24th
5:30 pm
Venue:
Fleming's Prime Steakhouse
2525 West End, Suite 220
Nashville, TN 37203
